We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Allergan Plc | LSE:0Y7T | London | Ordinary Share | IE00BY9D5467 | ALLERGAN ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 154.21 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDM0Y7T
RNS Number : 9158T
J.P. Morgan Securities LLC
19 November 2019
Ap27
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED
INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
Hot Features
Premium
1. KEY INFORMATION
Name of exempt principal J.P Morgan Securities LLC
trader
Company dealt in Allergan plc
=========================
Class of relevant security Ordinary Share
to which the dealings
being disclosed relate
(Note 1)
=========================
Date of dealing 18 November 2019
=========================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)
Long Short
Number (%) Number (%)
========= ====== =========== ======
3,490,864
(1) Relevant securities 5,241,522 1.60 1.06
================= ===================
(2) Derivatives (other 4,348,536
than options) 3,022,932 0.92 1.33
================= ===================
(3) Options and agreements
to purchase/sell 1,140,639 0.35 805,539 0.25
================= ===================
8,644,939
Total 9,405,093 2.87 2.64
================= ===================
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total
=================== =====================
Ap28
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 4)
Purchases 597 183.6100 USD
100 184.1179 USD
100 184.2444 USD
37 184.2600 USD
49 184.2760 USD
25 184.2969 USD
30 184.3200 USD
1,600 184.3206 USD
1,000 184.3290 USD
61 184.3300 USD
200 184.3450 USD
100 184.3500 USD
100 184.4000 USD
30 184.4100 USD
25 184.4172 USD
100 184.4200 USD
768 184.4348 USD
50 184.4376 USD
100 184.4500 USD
33 184.4511 USD
25 184.4556 USD
200 184.4600 USD
100 184.4609 USD
100 184.4700 USD
35 184.4800 USD
368 184.4809 USD
799 184.4900 USD
507,140 184.5000 USD
100 184.5100 USD
100 184.5113 USD
25 184.5124 USD
10 184.5285 USD
100 184.5442 USD
53 184.5500 USD
100 184.5530 USD
100 184.5600 USD
33 184.5689 USD
5 184.5699 USD
200 184.6050 USD
300 184.6833 USD
100 184.7500 USD
300 184.7633 USD
Sales 597 183.6100 USD
100 184.3500 USD
100 184.4000 USD
330 184.4031 USD
200 184.4150 USD
100 184.4200 USD
102 184.4296 USD
33 184.4450 USD
563,809 184.5000 USD
50 184.7500 USD
==================================== ===================
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 5) securities unit
e.g. CFD (Note 6) (Note 4)
Equity Swaps Long 425,963 184.5000
USD
Short 50
184.7500
USD
====================== =================== ==========
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 4)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
4)
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Nature of transaction Details Price per unit
(Note 7) (if applicable)
(Note 4)
Ap29
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on thisform or relating to the
voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 38.5(b) attached? (Note 8) YES
Date of disclosure 19 November 2019
Contact name Alwyn Basch
=============================
Telephone number 020 7742 7407
=============================
Name of offeree/offeror Allergan plc
with which connected
=============================
Nature of connection (Note Financial Advisor to Allergan
9) plc
=============================
Ap31
SUPPLEMENTAL FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 38.5(b)) OPEN POSITIONS (Note 1)
Product Written Number of Exercise Type, e.g. Expiry
name, or purchased relevant price American, date
e.g. call securities (Note European
option to which 2) etc.
the option
or derivative
relates
Put Option Written 65,100 95.00 American 17JAN20
Put Option Written 5,000 160.00 American 17JAN20
Put Option Written 5,000 140.00 American 17JAN20
Put Option Written 300,000 150.00 American 19JUN20
Put Option Written 5,000 140.00 American 19JUN20
Put Option Written 45,000 160.00 American 20DEC19
Put Option Written 233,402 104.11 European 23JAN20
Put Option Written 261,411 108.45 European 23JAN20
Put Option Purchased 88,000 150.00 American 20DEC19
Put Option Purchased 233,402 104.11 European 23JAN20
Put Option Purchased 261,411 108.45 European 23JAN20
Call Option Written 10,000 170.00 American 21FEB20
Call Option Written 5,000 210.00 American 17JAN20
Call Option Written 7,000 155.00 American 17JAN20
Call Option Written 100,363 104.11 European 23JAN20
Call Option Written 100,363 108.45 European 23JAN20
Call Option Purchased 20,000 185.00 American 21FEB20
Call Option Purchased 100,363 104.11 European 23JAN20
Call Option Purchased 100,363 108.45 European 23JAN20
============== =============== ========= =========== ========
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rules 8 and
38.5 of the Rules. If in doubt, consult the Panel.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ISEFKLFFKFFBFBD
(END) Dow Jones Newswires
November 19, 2019 06:14 ET (11:14 GMT)
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
